Fig 1: Ang2 plasma levels in untreated NSCLC patients and healthy control. (A) Overall, (B) by disease stage, and (C) by disease histology. Values are expressed as mean ± SD. *** P < 0.001, compared to control; ^^^ P < 0.001, ^ P = 0.03, compared to stage I; and # P = 0.03, compared to stage II. Ang2 = angiopoietin-2, NSCLC = nonsmall cell lung cancer, SD = standard deviation.
Fig 2: Ang2 plasma levels in perioperative NSCLC patients. Values are expressed as mean ± SD. *** P < 0.001, ** P = 0.003 (POD42) or 0.004 (POD56), compared to corresponding POD-1; ^^^P < 0.001, ^^P = 0.008, ^P = 0.02 (POD-1 (1, 3)), 0.03 (POD-1 (14)), 0.02 (POD-1 (42)), 0.04 (POD-1 (56)), compared to control. Ang2 = angiopoietin-2, NSCLC = nonsmall cell lung cancer, POD = postoperative day, POD-1 (1, 3) = preoperative control for POD1 and POD3 samples, POD-1 (14) = preoperative control for POD14 sample, POD-1 (28) = preoperative control for POD28 sample, POD-1 (42) = preoperative control for POD42 sample, POD-1 (56) = preoperative control for POD56 sample, SD = standard deviation.
Supplier Page from Abcam for Human Angiopoietin 2 ELISA Kit (ANG2)